Apogee Therapeutics

Apogee data hint at potential for long-lasting eczema drug
BioPharma Dive
Tue, 03/5/24 - 11:33 am
Apogee Therapeutics
clinical trials
eczema
APG777
NextGen Class of 2024: Top Life Sciences Startups to Watch This Year
BioSpace
Wed, 01/3/24 - 09:30 am
Rapport Therapeutics
Apogee Therapeutics
Cargo Therapeutics
Aera Therapeutics
Nido Biosciences
ReNAgade Therapeutics
Orbital Therapeutics
Abdera Therapeutics
SonoThera
Bitterroot Bio
Belharra Therapeutics
Kate Therapeutics
Convergent Therapeutics
Cajal Neuroscience
Matchpoint Therapeutics
Biopharma’s top 5 IPOs of 2023 (so far)
Pharma Voice
Thu, 11/30/23 - 10:01 am
biotech
IPOs
Acelyrin
Apogee Therapeutics
RayzeBio
Neumora Therapeutics
Mineralys Therapeutics
How biotech IPOs performed in the third quarter
BioPharma Dive
Tue, 10/3/23 - 10:28 am
biotech
IPOs
Adlai Nortye
RayzeBio
Neumora Therapeutics
Mira Pharmaceuticals
Turnstone Biologics
Apogee Therapeutics
Sagimet Biosciences
60 Degrees Pharma
Apogee, Sagimet overshoot IPO expectation as both biotechs land on Nasdaq
Fierce Biotech
Tue, 07/18/23 - 11:34 am
NASDAQ
IPOs
Apogee Therapeutics
Sagimet Biosciences
Biophama's flotation haul creeps higher
EP Vantage
Thu, 07/6/23 - 10:09 am
IPOs
biotech
Acelyrin
Apogee Therapeutics
Azitra
CytoMed Therapeutics
Intensity Therapeutics
Mineralys Therapeutics
Paragon Therapeutics
Sagimet Biosciences
Structure Therapeutics
Turnstone Biologics
Paragon Therapeutics Launches First Spinout, Apogee Therapeutics, to Advance Novel Therapies for Inflammatory and Immunological Conditions
Benzinga
Wed, 12/7/22 - 09:42 am
Paragon Therapeutics
Apogee Therapeutics
APG777
inflammatory disease